Prothrombin Time Testing Market

Prothrombin Time Testing Market Outlook

The prothrombin time testing market is likely to register a CAGR of 5% during the forecast period, and is anticipated to reach a market share of US$ 10.38 Bn in 2032, from US$ 6.07 Bn in 2021, owing to the public awareness regarding the benefits and effectiveness of these devices for detecting the blood disorders.

Attributes	Details
Prothrombin Time Testing Market CAGR	5%
Prothrombin Time Testing Market Size (2021)	US$ 6.07 Bn
Prothrombin Time Testing Market Size (2032)	US$ 10.38 Bn

The rising prevalence of cardiovascular disorders in the senior population is one of the primary factors driving the demand for Prothrombin time testing. Cardiovascular disease (CVD) and blood diseases are the main causes of death in Europe, South Asia, Africa, and the United States.

Due to an increase in the frequency of blood and cardiovascular illnesses, the global sales of prothrombin time testing is expected to develop significantly over the forecast period, thus generating a profitable opportunity for major participants in the prothrombin time testing market.

The fact that over half of all Americans are at risk for heart disease, and the percentage is rising, presents a strong chance for the sales of prothrombin time testing to grow. The major key player in the market is attempting to gain prothrombin time testing market share by including more and more technical advancements into their product, allowing it to become highly advanced and capable of producing precise results with minimal variation.

What Factors Influence the Growth of the Prothrombin Time Testing Market

Increased use of Point-Of-Care Testing (POCT) and home care goods is predicted to boost the sales of prothrombin time testing. Geriatric populations in various nations are more prone to cardiovascular and blood problems, which gives rise to the demand for prothrombin time testing.

Furthermore, public awareness of the benefits and usefulness of these devices in diagnosing blood problems is a crucial driver driving the demand for prothrombin time testing. Prothrombin time testing devices are getting more and more common as a result of technological developments, such as faster and easier-to-use devices with superior sensor technology, promoting the sales of prothrombin time testing.

Furthermore, physicians' preference for anticoagulation agents (such as warfarin), higher testing frequency, and strong reimbursements for medical practitioners are propelling the demand for prothrombin time testing forward.

What Restrains the Prothrombin Time Testing Market

However, the approval procedure has become time-consuming and complicated as a result of stringent restrictions imposed by various regulatory authorities, and this factor is projected to stifle the sales of the prothrombin time testing.

What is the Regional Outlook of the Prothrombin Time Testing Market

North America, South Asia, East Asia, Europe, Latin America, Oceania, and the Middle East and Africa are the seven regions that make up the global Prothrombin time testing market. The Prothrombin time testing market is expected to be dominated by the North American region, owing to its high-quality infrastructure that caters to the market's needs.

With the current change in adoption and expansion in the medical device market, the rising demand for Prothrombin Time Testing in South Asia might become a lucrative market opportunity for key players. The demand for prothrombin time testing is growing slowly in the Middle East and Africa due to poor product penetration.

Due to continuous development by major factors to improve the accuracy of test results, both established and emerging economies are moving at a good pace. The sales of prothrombin time testing are expected to rise during the forecast period.

What is the Competitive Outlook of the Prothrombin Time Testing Market

Some of the major players in the prothrombin time testing market are NIHON KOHDEN CORPORATION, SEKISUI MEDICAL, Coagulation Sciences LLC, Universal Biosensors, F. Hoffmann-La Roche, Sysmex Corporation, Medtronic, Micropoint Biosciences, ARKRAY, Diagnostica Stago S.A.S., HemoSonics, Beckman Coulter, Grifols, and Chrono-log Corporation, Abbott, Helena Laboratories, Thermo Fisher Scientific, Siemens Healthcare GmbH and others. With novel product formulations and launches, these prominent industry players are expected to boost prothrombin time testing market share growth.

• SPOTCHEM HS HS-7710, a blood coagulation testing product, was launched by ARKRAY, Inc. in 2019. It is faster and more efficient than other variations, and it enables for analysis in surgical areas utilizing entire blood samples. Furthermore, it is fully automated, attracting larger sales of prothrombin time testing. In terms of blood analysis in surgeries, this is unique and innovative. This highlights the importance of product development and, by extension, research and development in the market.
• CoaguChek Vantus was introduced by Hoffman-La Roche Ltd in 2018. It's a wireless coagulation testing system for home care settings that allows patients to perform self-tests. It primarily assesses the efficacy of blood thinners and transmits data to healthcare experts for examination.

Report Scope

Report Attribute	Details
Growth rate	CAGR of 5% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 - 2020
Forecast period	2022 - 2032
Quantitative units	Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered	Application, type, technology, end use, region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	NIHON KOHDEN CORPORATION, SEKISUI MEDICAL, Coagulation Sciences LLC, Universal Biosensors, F. Hoffmann-La Roche, Sysmex Corporation, Medtronic, Micropoint Biosciences, ARKRAY, Diagnostica Stago S.A.S., HemoSonics, Beckman Coulter, Grifols, and Chrono-log Corporation, Abbott, Helena Laboratories, Thermo Fisher Scientific, Siemens Healthcare GmbH and others
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.